• 78
  • Comment
  • Favorite

Bristol Myers Squibb Non-GAAP EPS of $1.93 Beats by $0.12, Revenue of $11.9B Beats by $400M, Cuts FY22 outlook

seekingalpha2022-07-27

Bristol Myers Squibb press release (NYSE:BMY): Q2 Non-GAAP EPS of $1.93 beats by $0.12.Revenue of $11.9B (+1.7% Y/Y) beats by $400M.Delivers Robust Revenue Growth of 11% from In-Line Products and ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

  • Bull1973
    ·2022-07-27
    Ok
    Reply
    Report
  • Zivcheah
    ·2022-07-27
    O
    Reply
    Report
  • Zarkness
    ·2022-07-27
    Hi 👋🏻 
    Reply
    Report
  • MoneyCentral
    ·2022-07-27
    Poor guidance
    Reply
    Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial